EGFR and lung carcinoma: Among miRNAs involved in the pathogenesis and response to therapy of lung cancer, there is miR-153-3p, a molecule lowly expressed in these cases of nonsmall-cell lung cancer resistant to the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor.